Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06987864) titled 'An Extension Clinical Study of BCD-148 for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria Previously Treated in Clinical Study No. BCD-148-2/NOCTURN' on May 16.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Biocad
Condition:
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Intervention:
Biological: eculizumab
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: April 13, 2020
Target Sample Size: 24
Countries of Recruitment:
Russi...